A generic drug is chemically identical to the brand — and competes only on price, racing its margin to the floor. In telehealth you're selling the same molecule as everyone else. Without a real reason to choose you, you're the generic. This worksheet finds the wedge that makes you the brand.
In GLP-1, weight loss, and most prescription telehealth, you are selling the same active ingredient as your competitors. You all have licensed physicians. You all clear the same eligibility checks. Prices are drifting toward the floor. So when a patient compares you to the brand beside you, the things you are proudest of — the medication, the credentials, the convenience — are the things everyone else also has.
That is the trap. Sameness wins you a price-sensitive patient who leaves the moment someone is cheaper or faster. Differentiation is what turns a one-time script into a patient who stays, refers, and forgives a hiccup. It is not a logo or a tagline. It is a clear, defensible reason you are the right choice for a specific person.
And convenience won't save you: it's the top reason patients use telehealth in the first place (65%, per the JD Power 2024 U.S. Telehealth Satisfaction Study), which means every competitor already promises it. What that same study ranks as the No. 1 driver of telehealth satisfaction isn't price or speed — it's trust. That's the ground you actually compete on.
You will rarely win on all six. Strong brands pick one or two, commit, and let the rest support them. As you read, mark the ones you could honestly own and defend — those are your candidates for the worksheet below.
The narrower the patient, the sharper the edge. "GLP-1 for perimenopausal women," "for post-bariatric regain," "for athletes protecting muscle" beats "weight loss for everyone."
What actually happens after the prescription: titration philosophy, follow-up cadence, side-effect support, labs, a plan to taper. Most brands go silent here — and "reviewing medication options" is the single biggest experience gap in telehealth (JD Power 2024). That silence is your opening.
A specific, defensible stance: "we taper you off, not keep you on forever," "muscle-first," "food and behavior alongside the drug." An opinion patients can agree with is memorable. A neutral one is forgettable.
The outcomes you track and report back — weight, but also lean mass, side-effect resolution, labs, adherence. Measuring something specific signals you practice medicine, not just ship vials.
Who the patient can reach, how fast, and how human it feels. In a category that defaults to a faceless intake form, a real, responsive care relationship is a retention engine.
The rigor competitors hide, you show: named clinical oversight, honest limitations, what you will not prescribe. In a category under regulatory scrutiny, visible trust is a feature, not fine print.
These show up on nearly every telehealth homepage. The test: if a competitor can copy your claim word-for-word and it stays true for them, it is table stakes, not a difference. Keep those claims if you like — but move them down the page and lead with something they cannot say.
The strongest wedge for a clinical founder usually comes from how you actually practice — not from a tagline a copywriter invents. That's the advantage you hold over a generic agency: they can make you sound different, but they can't decide what you stand for. The worksheet below turns your clinical judgment into a positioning a patient can feel in one screen.
Answer in your own words, as the clinician — not as a marketer. If a section is hard to answer, that is the gap a competitor is exploiting. The last block turns your answers into a single positioning sentence you can test on your homepage.
Who do you serve better than a generalist could?
What is true for them that isn't true for "everyone who wants to lose weight"?
What actually happens in week 1, month 1, month 6?
What do you do here that competitors leave silent about?
What do you believe about treating this that not everyone agrees with?
What will you not do or prescribe, on principle?
What outcome do you track beyond the number on the scale?
How would a patient know, concretely, that it's working?
Who can the patient reach, and how fast?
What does being your patient feel like vs. a faceless brand?
For [specific patient] who [situation], [your brand] is the telehealth [category] that [your wedge] — so they [real outcome], not just [the commodity outcome].
What in that sentence could a competitor not honestly copy?
Bring your filled worksheet. We will pressure-test the positioning, make sure the claims are defensible, and turn it into a launch foundation — messaging, website direction, and patient journey. That's the GTM Strategy engagement.
Telehealth usage and satisfaction figures from the JD Power 2024 U.S. Telehealth Satisfaction Study: convenience is the top reason patients use telehealth (65%), "level of trust" is the No. 1 satisfaction factor, and reviewing medication options is the largest experience gap.